0001593968-21-001687.txt : 20210623
0001593968-21-001687.hdr.sgml : 20210623
20210623163755
ACCESSION NUMBER: 0001593968-21-001687
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210616
FILED AS OF DATE: 20210623
DATE AS OF CHANGE: 20210623
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Torres Denice
CENTRAL INDEX KEY: 0001820278
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38958
FILM NUMBER: 211039108
MAIL ADDRESS:
STREET 1: 3 RABBIT RUN DRIVE
CITY: NEW HOPE
STATE: PA
ZIP: 18938
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Karuna Therapeutics, Inc.
CENTRAL INDEX KEY: 0001771917
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 270605902
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 99 HIGH STREET
STREET 2: 26TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02110
BUSINESS PHONE: 857-449-2244
MAIL ADDRESS:
STREET 1: 99 HIGH STREET
STREET 2: 26TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02110
4
1
primary_01.xml
PRIMARY DOCUMENT
X0306
4
2021-06-16
0001771917
Karuna Therapeutics, Inc.
KRTX
0001820278
Torres Denice
99 HIGH STREET, 26TH FLOOR
BOSTON
MA
02110
true
false
false
false
Option (right to buy)
128.01
2021-06-16
4
A
false
8500
0
A
2031-06-15
Common Stock
8500
8500
D
This option shall vest in full upon the earlier of (i) June 16, 2022, and (ii) the 2022 annual meeting of the Issuer's stockholders.
/s/ Troy Ignelzi, Attorney-in-Fact
2021-06-23